Key result
Direct DNA sequencing followed by whole-exome sequencing achieved a pathogenic mutation detection rate of 44% in cases of exertion-related sudden unexplained death in the young.
Why the study?
Does whole-exome sequencing improve the diagnostic yield of pathogenic mutations in exertion-related sudden unexplained death in the young?
Observational (n=32)
Does whole-exome sequencing improve the diagnostic yield of pathogenic mutations in exertion-related sudden unexplained death in the young?
Molecular screening using direct DNA sequencing followed by whole-exome sequencing yields a pathogenic mutation in 44% of exertion-related sudden unexplained death in the young, with the highest diagnostic yield in children under 10 years of age.
Answers are grounded in this paper and cite their sources.
May support molecular autopsy after exertion-related sudden death; leaves open prospective validation of routine sequencing.
BACKGROUND: Targeted postmortem genetic testing of the 4 major channelopathy-susceptibility genes (KCNQ1, KCNH2, SCN5A, and RYR2) have yielded putative pathogenic mutations in ≤30% of autopsy-negative sudden unexplained death in the young (SUDY) cases with highest yields derived from the subset of exertion-related SUDY. Here, we evaluate the role of whole-exome sequencing in exertion-related SUDY cases. METHODS AND RESULTS: From 1998 to 2010, 32 cases of exertion-related SUDY were referred by Medical Examiners for a cardiac channel molecular autopsy. A mutational analysis of the major long-QT syndrome-susceptibility genes (KCNQ1, KCNH2, and SCN5A) and catecholaminergic polymorphic ventricular tachycardia-susceptibility gene (RYR2) identified a putative pathogenic mutation in 11 cases. Whole-exome sequencing was performed on the remaining 21 targeted gene-negative SUDY cases. After whole-exome sequencing, a gene-specific surveillance of all genes (N=100) implicated in sudden death was performed to identify putative pathogenic mutation(s). Three of these 21 decedents had a clinically actionable, pathogenic mutation (CALM2-F90L, CALM2-N98S, and PKP2-N634fs). Of the 18 remaining cases, 7 hosted at least 1 variant of unknown significance with a minor allele frequency <1:20 000. The overall yield of pathogenic mutations was higher among decedents aged 1 to 10 years (10/11, 91%) than those aged 11 to 19 years (4/21, 19%, P=0.0001). CONCLUSIONS: Molecular screening in this clinical scenario is appropriate with a pathogenic mutation detection rate of 44% using direct DNA sequencing followed by whole-exome sequencing. Only 5 of the 100 interrogated sudden death genes hosted actionable pathogenic mutations for more than one third of these exertion-related, autopsy-negative SUDY cases.
No takes yet. Share an insight, caveat, or question.
Anderson et al. (2016) conducted an observational in Exertion-related sudden unexplained death in the young (n=32). Direct DNA sequencing followed by whole-exome sequencing was evaluated on Pathogenic mutation detection rate. Direct DNA sequencing followed by whole-exome sequencing achieved a pathogenic mutation detection rate of 44% in cases of exertion-related sudden unexplained death in the young.
Synapse has enriched 10 related papers. Consider them for comparative context: